Christopher Navara to Antineoplastic Agents
This is a "connection" page, showing publications Christopher Navara has written about Antineoplastic Agents.
Connection Strength
0.315
-
Navara CS, Benyumov A, Vassilev A, Narla RK, Ghosh P, Uckun FM. Vanadocenes as potent anti-proliferative agents disrupting mitotic spindle formation in cancer cells. Anticancer Drugs. 2001 Apr; 12(4):369-76.
Score: 0.118
-
Uckun FM, Mao C, Jan ST, Huang H, Vassilev AO, Navara CS, Narla RK. Spongistatins as tubulin targeting agents. Curr Pharm Des. 2001 Sep; 7(13):1291-6.
Score: 0.030
-
Ghosh P, Ghosh S, Navara C, Narla RK, Benyumov A, Uckun FM. X-ray structure, solution properties, and biological activity profile of vanadocene(IV) acetylacetonate complex,. J Inorg Biochem. 2001 Apr; 84(3-4):241-53.
Score: 0.030
-
Uckun FM, Mao C, Jan ST, Huang H, Vassilev AO, Sudbeck EA, Navara CS, Narla RK. SPIKET and COBRA compounds as novel tubulin modulators with potent anticancer activity. Curr Opin Investig Drugs. 2000 Oct; 1(2):252-6.
Score: 0.029
-
Jan ST, Mao C, Vassilev AO, Navara CS, Uckun FM. COBRA-1, a rationally-designed epoxy-THF containing compound with potent tubulin depolymerizing activity as a novel anticancer agent. Bioorg Med Chem Lett. 2000 Jun 05; 10(11):1193-7.
Score: 0.028
-
Uckun FM, Mao C, Vassilev AO, Navara CS, Narla RK, Jan ST. A rationally designed anticancer drug targeting a unique binding cavity of tubulin. Bioorg Med Chem Lett. 2000 May 15; 10(10):1015-8.
Score: 0.028
-
Narla RK, Dong Y, D'Cruz OJ, Navara C, Uckun FM. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent. Clin Cancer Res. 2000 Apr; 6(4):1546-56.
Score: 0.028
-
Ghosh S, Zheng Y, Jun X, Narla RK, Mahajan S, Navara C, Mao C, Sudbeck EA, Uckun FM. Alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl] propenamide: an inhibitor of the epidermal growth factor receptor tyrosine kinase with potent cytotoxic activity against breast cancer cells. Clin Cancer Res. 1998 Nov; 4(11):2657-68.
Score: 0.025